Breast cancer remains a leading cause of mortality among women worldwide, highlighting the critical need for effective early detection methods. DNA methylation, involving variations in methylation levels, serves as a significant biomarker for identifying cancerous changes at an early stage.
No takes yet. Share an insight, caveat, or question.
Velayutham Pavanasam (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: